Cold Chain Management in China
|
About Cold Chain Focus CHINA
|
|
The nature and the high value of the bio/pharmaceutical temperature controlled supply chain makes managing this very challenging and expensive process. China is at the point of becoming the largest biotechnology/pharmaceutical market globally but the country is still far from developing a comprehensive and efficient cold chain distribution system for bio/ pharmaceutical products and clinical trial supplies. Also, the environmental, structural and regulatory obstacles are also massive for bio/pharma companies in China.
Learn how China is meeting the challenges of Cold Chain in this resource centre
-
Promoting Quality and Temperature Controlled Distribution in South Africa -
Biopharma Drives Cold Chain in Canada -
How to Develop a Compliant Cool Chain Quality System -
Cutting Waste in the Cold Chain - Geraint Thomas, Laminar Medica -
Stability Data in the Cold Chain -
Will Pharma Ever be Able to Fully Embrace Social Media? -
Biopharmaceutical Cold Chain: Investing in the MENA Region -
Challenges for Successful and Cost-Efficient Cold Chain Management -
Can the Cold Chain Ever Become Truly Sustainable? -
Keeping Cool Under Increasing Pressure
* = required.
-
Contributor: Cold Chain IQ -
Contributor: Cold Chain IQ -
Contributor: Andrea Charles -
Contributor: Cold Chain IQ -
Contributor: Huo Peiqiong -
Contributor: RuiQi Wang -
Contributor: Andrea Charles -
Contributor: Cold Chain IQ -
Contributor: Pharma IQ






















Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!